Français
ItalianoBond Bristol Myers Squibb 7.15% ( US110122AA65 ) in USD
| Issuer | Bristol Myers Squibb | ||||||||||||
| Market price | 100 % ▲ | ||||||||||||
| Country |  United States
|
||||||||||||
| ISIN code |
 US110122AA65 ( in USD )
|
||||||||||||
| Interest rate | 7.15% per year ( payment 2 times a year) | ||||||||||||
| Maturity | 06/15/2023 - Bond has expired | ||||||||||||
| Minimal amount | 1 000 USD | ||||||||||||
| Total amount | 350 000 000 USD | ||||||||||||
| Cusip | 110122AA6 | ||||||||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. The Bond issued by Bristol Myers Squibb ( United States ) , in USD, with the ISIN code US110122AA65, pays a coupon of 7.15% per year. The coupons are paid 2 times per year and the Bond maturity is 06/15/2023 |
||||||||||||
| |||||||||||||